APA (7th ed.) Citation

T, R., D, S., P, G., C, v. d. B., C, B., E, L., . . . C, S. (2026). IPSS-M downstaging before transplantation does not improve the prognosis of patients with myelodysplastic neoplasms. Bone marrow transplantation, 61(5), 584. https://doi.org/10.1038/s41409-026-02845-w

Chicago Style (17th ed.) Citation

T, Richardson, et al. "IPSS-M Downstaging Before Transplantation Does Not Improve the Prognosis of Patients with Myelodysplastic Neoplasms." Bone Marrow Transplantation 61, no. 5 (2026): 584. https://doi.org/10.1038/s41409-026-02845-w.

MLA (9th ed.) Citation

T, Richardson, et al. "IPSS-M Downstaging Before Transplantation Does Not Improve the Prognosis of Patients with Myelodysplastic Neoplasms." Bone Marrow Transplantation, vol. 61, no. 5, 2026, p. 584, https://doi.org/10.1038/s41409-026-02845-w.